For some women with HIV, protease inhibitors may add to diabetes risk

07/2/2014 | Aidsmap

A study in the journal AIDS found that protease inhibitor-based therapy was associated with an increased likelihood of the development of diabetes in some women with a genetic risk for the condition. The study highlights the need for individualized HIV/AIDS regimens based on genetic risk factors, researchers said.

View Full Article in:

Aidsmap

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior or Principal Consultant
PAREXEL International
Nationwide, SL_Nationwide
MGR POST MARKET STUDIES - 14000001LK
Abbott
Santa Ana, CA
Senior Financial Analyst - Growing Manager Care Health Org
Fallon Community Health Plan
Worcester, MA
Assistant General Counsel, Regulatory
Cardinal Health
Waukegan, IL
Chief Executive Officer
UCare Minnesota
Minneapolis, MN